https://nvca.org/about-us/policy-blog/
Policy BlogPolicy Blog
The world has anxiously waited for encouraging news about COVID-19 vaccine candidates. Happily, this news came right before Thanksgiving, with Moderna reporting that its vaccine is more than 94% effective and Pfizer indicating that its vaccine was similarly effective.
Read more
https://nvca.org/wp-content/uploads/2019/06/42865ff45b916762c541e2bffe9fa791b4165a45.png
0
0
Jeff Farrah
https://nvca.org/wp-content/uploads/2019/06/42865ff45b916762c541e2bffe9fa791b4165a45.png
Jeff Farrah2020-11-30 04:31:062020-12-01 05:31:33Creating the Next Moderna: What VC Offers the World and 3 Public Policy LessonsAt NVCA, we understand that venture capital powers the American economy, and we advocate that venture is a key component to keeping our economy strong through the COVID-19 pandemic fallout. American startups are the most innovative companies in the world, and many that are backed by VC are currently using their resources and human capital […]
Read more
https://nvca.org/wp-content/uploads/2019/06/42865ff45b916762c541e2bffe9fa791b4165a45.png
0
0
Devin Miller
https://nvca.org/wp-content/uploads/2019/06/42865ff45b916762c541e2bffe9fa791b4165a45.png
Devin Miller2020-11-04 18:59:372020-11-19 02:10:09Venture Capital Fuels America’s Recovery: InfographicWelcome to the first blog in our VC Policy Pulse series, where we speak with a VC investor on a policy issue that is having a major impact on the VC and startup ecosystem. Today, we’re hearing from Mark Kvamme, Co-Founder & Partner at Drive Capital and former NVCA Board Member, about the effects of […]
Read more
https://nvca.org/wp-content/uploads/2019/06/42865ff45b916762c541e2bffe9fa791b4165a45.png
0
0
Devin Miller
https://nvca.org/wp-content/uploads/2019/06/42865ff45b916762c541e2bffe9fa791b4165a45.png
Devin Miller2020-09-29 16:50:002020-09-29 16:50:00VC Policy Pulse: the Volcker Rule with Mark KvammeAs the COVID-19 pandemic continues to impact the world, many U.S. VC-backed startups are helping fight the virus by developing, testing, and implementing treatments that can manage, alleviate, or even prevent the symptoms of COVID-19.  The venture industry is proud to support these innovative companies by providing capital and strategic guidance that is essential to […]
Read more
https://nvca.org/wp-content/uploads/2019/06/42865ff45b916762c541e2bffe9fa791b4165a45.png
0
0
Devin Miller
https://nvca.org/wp-content/uploads/2019/06/42865ff45b916762c541e2bffe9fa791b4165a45.png
Devin Miller2020-06-25 17:44:032020-06-25 17:44:038 VC-Backed Startups Helping Treat COVID-19Many of America’s startups are currently researching and producing advanced technologies needed to fight COVID-19. Nimble, high-growth companies have frequently re-defined the boundaries of science and technology, and many startups are using their capabilities and expertise to find and develop the technology-driven solutions needed to get past this pandemic.
Read more
https://nvca.org/wp-content/uploads/2019/06/42865ff45b916762c541e2bffe9fa791b4165a45.png
0
0
Devin Miller
https://nvca.org/wp-content/uploads/2019/06/42865ff45b916762c541e2bffe9fa791b4165a45.png
Devin Miller2020-05-28 15:23:142020-05-29 15:22:07How 10 VC-Backed Startups are Combating COVID-19We worked with Ross DeVol, President and CEO of Heartland Forward, on this partner blog post to highlight the importance of entrepreneurs and startups during this crisis and how they could be the engine to get people back to work. It should come as no surprise to the NVCA community that entrepreneurs are critical to […]
Read more
https://nvca.org/wp-content/uploads/2019/06/42865ff45b916762c541e2bffe9fa791b4165a45.png
0
0
Ross DeVol
https://nvca.org/wp-content/uploads/2019/06/42865ff45b916762c541e2bffe9fa791b4165a45.png
Ross DeVol2020-05-13 17:23:152020-06-08 18:27:50How Startups and Entrepreneurs Can Power the Economic RecoveryThe U.S. startup ecosystem has rapidly entered a new chapter of what will be a turbulent period over at least the next several quarters. Investment in the startup ecosystem is expected to drop significantly at a time when the country needs it most for company and job creation towards economic recovery from the global pandemic. […]
Read more
https://nvca.org/wp-content/uploads/2019/06/42865ff45b916762c541e2bffe9fa791b4165a45.png
0
0
Maryam Haque
https://nvca.org/wp-content/uploads/2019/06/42865ff45b916762c541e2bffe9fa791b4165a45.png
Maryam Haque2020-04-28 18:00:152020-05-26 19:56:16Startup Ecosystem Faces Capital Crunch over Coming Months – What We Expect & Why It MattersThe Treasury Department recently released the long awaited final rules implementing the Foreign Investment Risk Review Modernization Act (FIRRMA), and they go into effect February 13, 2020. Through FIRRMA, Congress gave CFIUS significant new powers to police investments into certain U.S. companies and has made CFIUS highly relevant in the startup ecosystem. CFIUS’s power was […]
Read more
https://nvca.org/wp-content/uploads/2019/06/42865ff45b916762c541e2bffe9fa791b4165a45.png
0
0
Jeff Farrah
https://nvca.org/wp-content/uploads/2019/06/42865ff45b916762c541e2bffe9fa791b4165a45.png
Jeff Farrah2020-01-27 21:03:202020-05-12 19:38:37CFIUS & VC: 3 Takeaways from the Final Rules and What Investors Must KnowWhat can NIH offer to NVCA member firm’s life science portfolio companies? How can you get access to NIH funded companies? Since when does NIH have Entrepreneurs in Residence? Check out the answers to these questions and more in our first Q&A session with NIH investment executives, Dr. Ethel Rubin and John Sullivan. To cultivate […]
Read more
https://nvca.org/wp-content/uploads/2019/06/42865ff45b916762c541e2bffe9fa791b4165a45.png
0
0
Charlotte Savercool
https://nvca.org/wp-content/uploads/2019/06/42865ff45b916762c541e2bffe9fa791b4165a45.png
Charlotte Savercool2019-07-11 10:20:202019-07-11 10:20:20NIH is the World’s Largest Early Stage Life Sciences Investor That You Didn't Know AboutAs the entrepreneurial ecosystem and D.C. continue to intersect more and more, it’s crucial that VCs and startups engage with policymakers on policies and ideas that impact America’s startup industry. Recently, NVCA brought the ecosystem and D.C. together at our annual VCs-to-DC event. VCs-to-DC convened VCs, founders, and policymakers in our nation’s capital to take […]
Read more
https://nvca.org/wp-content/uploads/2019/06/42865ff45b916762c541e2bffe9fa791b4165a45.png
0
0
Jeff Farrah
https://nvca.org/wp-content/uploads/2019/06/42865ff45b916762c541e2bffe9fa791b4165a45.png
Jeff Farrah2019-06-19 13:46:482019-10-29 19:42:18VCs Advocate for Startup Policy at VCs-to-DCPage 1 of 6123›»
LATEST NEWS The world has anxiously waited for encouraging news about COVID-19 vaccine candidates. Happily, this news came right before Thanksgiving, with Moderna reporting that its vaccine is more than 94% effective and Pfizer indicating that its vaccine was similarly effective.
Read more
https://nvca.org/wp-content/uploads/2019/06/42865ff45b916762c541e2bffe9fa791b4165a45.png
0
0
Jeff Farrah
https://nvca.org/wp-content/uploads/2019/06/42865ff45b916762c541e2bffe9fa791b4165a45.png
Jeff Farrah2020-11-30 04:31:062020-12-01 05:31:33Creating the Next Moderna: What VC Offers the World and 3 Public Policy LessonsWelcome to our Member Spotlight series where we give a profile overview of our many diverse members. For this deep dive, we spoke to Monica Johnson, Partner & CFO at NGP Capital.
Read more
https://nvca.org/wp-content/uploads/2019/06/42865ff45b916762c541e2bffe9fa791b4165a45.png
0
0
Cassie Ann Kiggen
https://nvca.org/wp-content/uploads/2019/06/42865ff45b916762c541e2bffe9fa791b4165a45.png
Cassie Ann Kiggen2020-11-20 01:41:412020-11-20 02:16:44NVCA Member Spotlight: NGP Capital
Stay Connected. Be the first to hear about upcoming initiatives.
First Name*Last Name*Organization*Email*
We respect your privacy and take protecting it seriously. Learn more in our Privacy Policy.
Headquarters
25 Massachusetts Avenue NW
Suite 730
Washington, D.C. 20001
Phone: 202.864.5920
Fax: 202.864.5930
San Francisco Office
214 Grant Avenue
Suite 325
San Francisco, CA 94108
Scroll to top